# "REACT-FM-EXT": Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study

> **NCT05149222** · NA · COMPLETED · sponsor: **Swing Therapeutics, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DEVICE:** Digital ACT

## Key facts

- **NCT ID:** NCT05149222
- **Lead sponsor:** Swing Therapeutics, Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2024-04-14
- **Final completion:** 2024-04-14
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05149222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05149222, ""REACT-FM-EXT": Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05149222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*